Costs and Benefits of Immunotherapies or Depot Medications for the Treatment of Drug Abuse
作者： Tracy G Myers , Henrick J Harwood
DOI:
关键词:
摘要:
参考文章(22)
Schwartz Ej, Blower S, Mills J, Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. Aids Reviews. ,vol. 5, pp. 113- 125 ,(2003)
George De Leon, The Therapeutic Community: Theory, Model, and Method ,(2000)
John Pepper, Charles F. Manski, Carol Petrie, Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us ,(2001)
Avram Goldstein, Addiction: from biology to drug policy ,(1994)
Philip Bean, Drugs and Crime ,(2001)
C. Rydell, Susan Sohler Everingham, Controlling Cocaine: Supply Versus Demand Programs ,(1995)
C. P. Rydell, Susan S. Everingham, Modeling the Demand for Cocaine ,(1995)
Bertha K. Madras, Office of National Drug Control Policy Annals of the New York Academy of Sciences. ,vol. 1187, pp. 370- 402 ,(2010) , 10.1111/J.1749-6632.2009.05278.X
Robert MacCoun, Peter Reuter, Thomas Schelling, Assessing alternative drug control regimes Journal of Policy Analysis and Management. ,vol. 15, pp. 330- 352 ,(1996) , 10.1002/(SICI)1520-6688(199622)15:3<330::AID-PAM1>3.0.CO;2-J
John A. Fairbank, Georgez H. Dunteman, Ward S. Condelli, Do Methadone Patients Substitute Other Drugs for Heroin? Predicting Substance Use at 1-Year Follow-up American Journal of Drug and Alcohol Abuse. ,vol. 19, pp. 465- 474 ,(1993) , 10.3109/00952999309001635